- Home
- DNTH vs ORC Comparison
DNTH vs ORC Comparison
Compare DNTH & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- ORC
- Stock Information
- Founded
- DNTH 2015
- ORC 2010
- Country
- DNTH United States
- ORC United States
- Employees
- DNTH N/A
- ORC N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- ORC Real Estate Investment Trusts
- Sector
- DNTH Health Care
- ORC Real Estate
- Exchange
- DNTH Nasdaq
- ORC Nasdaq
- Market Cap
- DNTH 657.0M
- ORC 660.1M
- IPO Year
- DNTH N/A
- ORC 2013
- Fundamental
- Price
- DNTH $19.59
- ORC $7.16
- Analyst Decision
- DNTH Strong Buy
- ORC Buy
- Analyst Count
- DNTH 8
- ORC 4
- Target Price
- DNTH $54.33
- ORC $9.50
- AVG Volume (30 Days)
- DNTH 251.8K
- ORC 3.7M
- Earning Date
- DNTH 05-16-2025
- ORC 04-24-2025
- Dividend Yield
- DNTH N/A
- ORC 20.14%
- EPS Growth
- DNTH N/A
- ORC N/A
- EPS
- DNTH N/A
- ORC 0.46
- Revenue
- DNTH $6,235,000.00
- ORC $52,240,000.00
- Revenue This Year
- DNTH N/A
- ORC N/A
- Revenue Next Year
- DNTH N/A
- ORC $51.24
- P/E Ratio
- DNTH N/A
- ORC $15.59
- Revenue Growth
- DNTH 120.63
- ORC N/A
- 52 Week Low
- DNTH $13.37
- ORC $5.69
- 52 Week High
- DNTH $32.27
- ORC $9.01
- Technical
- Relative Strength Index (RSI)
- DNTH 45.90
- ORC 52.47
- Support Level
- DNTH $20.76
- ORC $6.28
- Resistance Level
- DNTH $22.14
- ORC $7.44
- Average True Range (ATR)
- DNTH 1.50
- ORC 0.18
- MACD
- DNTH -0.13
- ORC 0.07
- Stochastic Oscillator
- DNTH 5.53
- ORC 68.51
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.